Caffeine 7-N-demethylation and C-8-oxidation mediated by liver microsomal cytochrome P450 enzymes in common marmosets

References

• Berthou F, Flinois JP, Ratanasavanh D, et al. (1991). Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes. Drug Metab Dispos 19:561–7
   PubMed Web of Science ®Google Scholar
• Berthou F, Guillois B, Riche C, et al. (1992). Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica 22:671–80
   PubMed Web of Science ®Google Scholar
• Grant DM, Campbell ME, Tang BK, Kalow W. (1987). Biotransformation of caffeine by microsomes from human liver. Kinetics and inhibition studies. Biochem Pharmacol 36:1251–60
   PubMed Web of Science ®Google Scholar
• Grant DM, Tang BK, Kalow W. (1983). Variability in caffeine metabolism. Clin Pharmacol Ther 33:591–602
   PubMed Web of Science ®Google Scholar
• Gu L, Gonzalez FJ, Kalow W, Tang BK. (1992). Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 2:73–7
   PubMedGoogle Scholar
• Iwasaki K, Uno Y. (2009). Cynomolgus monkey CYPs: a comparison with human CYPs. Xenobiotica 39:578–81
   PubMed Web of Science ®Google Scholar
• Kimura M, Shimizu M, Kiyotani K, et al. (2012). Cytochrome P450 2A6 phenotyping based on dietary caffeine intake in a Japanese population of non-smokers. Drug Metab Lett 6:67–72
   PubMedGoogle Scholar
• Kimura M, Yamazaki H, Fujieda M, et al. (2005). CYP2A6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans. Drug Metab Dispos 33:1361–6
   PubMed Web of Science ®Google Scholar
• Kot M, Daniel WA. (2008). The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: an in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms. Biochem Pharmacol 76:543–51
   PubMed Web of Science ®Google Scholar
• Koyanagi T, Nakanishi Y, Murayama N, et al. (2015). Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole, and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation. Xenobiotica 45:312–21
   PubMed Web of Science ®Google Scholar
• Mogi M, Toda A, Iwasaki K, et al. (2012). Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to Microminipigs. J Toxicol Sci 37:1157–64
   PubMed Web of Science ®Google Scholar
• Sakai C, Iwano S, Yamazaki Y, et al. (2014). Species differences in the pharmacokinetic parameters of cytochrome P450 probe substrates between experimental animals, such as mice, rats, dogs, monkeys, and microminipigs, and humans. J Drug Metab Toxicol 5:173
   Google Scholar
• Saruwatari J, Nakagawa K, Shindo J, et al. (2002). A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test. Clin Pharmacol Ther 72:200–8
   PubMed Web of Science ®Google Scholar
• Sasaki E. (2015). Prospects for genetically modified non-human primate models, including the common marmoset. Neurosci Res 93:110–15
   PubMed Web of Science ®Google Scholar
• Shimizu M, Iwano S, Uno Y, et al. (2014). Qualitative de novo analysis of full length cDNA and quantitative analysis of gene expression for common marmoset (Callithrix jacchus) transcriptomes using parallel long-read technology and short-read sequencing. PLoS One 9:e100936
   PubMed Web of Science ®Google Scholar
• Tantcheva-Poor I, Zaigler M, Rietbrock S, Fuhr U. (1999). Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 9:131–44
   PubMedGoogle Scholar
• Turpault S, Brian W, Van HR, et al. (2009). Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. Br J Clin Pharmacol 68:928–35
   PubMed Web of Science ®Google Scholar
• Uehara S, Inoue T, Utoh M, et al. (2015a). Simultaneous pharmacokinetics evaluation of human cytochrome P450 probes, caffeine, warfarin, omeprazole, metoprolol, and midazolam, in common marmosets (Callithrix jacchus). Xenobiotica. [Epub ahead of print]. doi: 10.3109/00498254.2015.1057270
   Web of Science ®Google Scholar
• Uehara S, Uno Y, Hagihira Y, et al. (2015b). Marmoset cytochrome P450 2D8 in livers and small intestines metabolizes typical human P450 2D6 substrates, metoprolol, bufuralol, and dextromethorphan. Xenobiotica 45:766–72
   PubMed Web of Science ®Google Scholar
• Uehara S, Uno Y, Inoue S, et al. (2015c). Novel marmoset cytochrome P450 2C19 in livers efficiently metabolizes human P450 2C9 and 2C19 substrates, S-warfarin, tolbutamide, flurbiprofen, and omeprazole. Drug Metab Dispos 43:1408–16
   PubMed Web of Science ®Google Scholar
• Uehara S, Uno Y, Inoue T, et al. (2015d). Activation and deactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by cytochrome P450 enzymes and flavin-containing monooxygenases in common marmosets (Callithrix jacchus). Drug Metab Dispos 43:735–42
   PubMed Web of Science ®Google Scholar
• Uehara S, Uno Y, Inoue T, et al. (2015e). Substrate selectivities and catalytic activities of marmoset liver cytochrome P450 2A6 differed from those of human P450 2A6. Drug Metab Dispos 43:969–76
   PubMed Web of Science ®Google Scholar
• Utoh M, Murayama N, Uno Y, et al. (2013). Monkey liver cytochrome P450 2C9 is involved in caffeine 7-N-demethylation to form theophylline. Xenobiotica 43:1037–42
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Nakamura M, Komatsu T, et al. (2002). Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Express Purif 24:329–37
   PubMed Web of Science ®Google Scholar